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Genetic variation in the human population may lead to functional variants of genes that contribute to risk for
common chronic diseases such as cancer. In an effort to detect such possible predisposing variants, we constructed
haplotypes for a candidate gene and tested their efficacy in association studies. We developed haplotypes consisting
of 14 biallelic neutral-sequence variants that span 142 kb of the ATM locus. ATM is the gene responsible for the
autosomal recessive disease ataxia-telangiectasia (AT). These ATM noncoding single-nucleotide polymorphisms
(SNPs) were genotyped in nine CEPH families (89 individuals) and in 260 DNA samples from four different ethnic
origins. Analysis of these data with an expectation-maximization algorithm revealed 22 haplotypes at this locus,
with three major haplotypes having frequencies .10. Tests for recombination and linkage disequilibrium (LD)
show reduced recombination and extensive LD at the ATM locus, in all four ethnic groups studied. The most
striking example was found in the study population of European ancestry, in which no evidence for recombination
could be discerned. The potential of ATM haplotypes for detection of genetic variants through association studies
was tested by analysis of 84 individuals carrying one of three ATM coding SNPs. Each coding SNP was detected
by association with an ATM haplotype. We demonstrate that association studies with haplotypes for candidate
genes have significant potential for the detection of genetic backgrounds that contribute to disease.
Introduction
Qualifying and quantifying the genetic contribution to
the etiology of common complex disease remains one of
the great quests of modern medical genetics. The com-
plexity of multifactorial diseases challenges the para-
digms and tools of conventional genetic research. Tra-
ditional methods of genetic analysis do not have the
statistical power or sensitivity for the task of teasing out
a genetic contribution when it is subtle or when several
genes may be working together (Risch and Merikangas
1996). Genomewide association studies, as well as pop-
ulation studies with candidate genes, have been touted
as possible alternatives to linkage analysis (Risch and
Merikangas 1996; Collins et al. 1997; Kruglyak 1999;
Risch 2000). These approaches focus on finding either
a causative variant or a genetic variant closely linked
with the disease phenotype. Some studies utilizing single-
nucleotide polymorphisms (SNPs) have succeeded in de-
tecting the risk for disease, notably in the case of the
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apolipoprotein type E (apoE) gene and both coronary
artery disease (Boerwinkle et al. 1996) and Alzheimer
disease (Strittmatter and Roses 1995). These studies
were able to directly assess the risk conferred by known
apoE functional variants. In some other cases, however,
the attempt to correlate single-locus alleles with phe-
notypes have produced mixed results (Josefsson et al.
1998; Kraft et al. 1998; Storey et al. 1998).
Haplotype association with disease by the linkage dis-
equilibrium (LD) approach has been used successfully
for the identification of genomic regions containing loci
responsible for disease phenotypes (MacDonald et al.
1992; Yu et al. 1996). The same principle can be applied
by use of haplotypes of biallelic markers to detect dis-
ease association. Using several SNPs distributed across
100–200 kb should result in statistical sensitivity that
is greater than that in studies using fewer loci. Another
strength of such an approach is the ability to use purely
epidemiological populations for detection of chromo-
somal backgrounds lending risk for disease.
All of these approaches are, to one extent or another,
dependent on LD. An understanding of LD relationships
between markers will inform the efficacy and design of
future LD-based strategies for detection of genetic con-
tributions to common disease. Simulation studies have
estimated the length of useful LD to be as low as 3 kb
(Kruglyak 1999). Recent investigations support the no-
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tion that LD varies throughout the genome (Collins et
al. 1999; Taillon-Miller et al. 2000) and that it can
extend to considerable lengths, such as several hundred
kilobases (Collins et al. 1999; Eaves et al. 2000;Moffatt
et al. 2000; Taillon-Miller et al. 2000). Reports of such
extreme differences indicate the need for further study
of the extent and nature of LD.
Allelic variation leading to functional variants of
genes may predispose to risk for seemingly sporadic
cases of common disease (Lander 1996; Collins et al.
1997). Here we describe a strategy for exploring the
possible effects of functional variants of genes involved
in familial cancers. We use a resequencing approach to
detect SNPs across a large (184 kb) genomic region
containing the ATM gene. ATM is responsible for the
autosomal recessive disease ataxia-telangiectasia (A-T)
(Savitsky et al. 1995). A-T is characterized by cerebellar
ataxia, oculocutaneous telangiectasia, immune defi-
ciency, sensitivity to ionizing radiation, increased inci-
dence of tumors, and chromosomal instability (Gatti et
al. 1991). A-T heterozygotes may be at increased risk
for development of cancers, most prominently—and
controversially—breast cancer (Swift et al. 1987, 1991;
Morrell et al. 1990; Stankovic et al. 1998; Gatti et al.
1999). With carrier frequencies estimated to be from
0.5% to 11% (Swift et al. 1986; Gatti et al. 1999),
assessment of cancer risk for this population is a com-
pelling endeavor. In addition, the ATM-gene product is
centrally involved in cellular responses to DNA damage,
including DNA double-strand break repair and signal-
ing leading to cell-cycle arrest and apoptosis (reviewed
in Rotman and Shiloh 1999). We genotyped 295 indi-
viduals from four ethnic groups, for 14 SNP markers
that spanned 142 kb. An expectation-maximization al-
gorithm estimated 22 ATM haplotypes from these data.
Tests for recombination and LD revealed (a) no evidence
for recombination in the white European American
study population and (b) perfect disequilibrium extend-
ing the full length marked by these SNPs. We then con-
ducted a model association study with these haplotypes
and a population of samples that possessed one of three
different coding SNPs (cSNPs) in the ATM gene. The
results of this study provide strong support for the utility
of complex SNP haplotypes as a means to detect poly-
morphisms in a population-based sample.
Subjects and Methods
Human Subjects
For SNP discovery, genomic DNA from five unrelated
white European Americans was sequenced. This DNA
was extracted from lymphoblast and fibroblast cell lines.
For SNP genotyping, individuals from four ethnic groups
were sampled: African American ( ), Asian Amer-np 71
ican ( ), white European American ( ), andnp 39 np 77
Hispanic ( ). All ethnic samples (self-describednp 73
ethnicity) were part of a collection of 941 DNA purified
samples from anonymous blood donors in community-
based blood drives in southeastern and central Texas.
Samples analyzed in the model association study were
also from this DNA collection. Members of nine CEPH
families were also analyzed. In all families, four grand-
parents, two parents, and four children were examined;
since two of these families share a grandparent, 89 in-
dividuals were genotyped, and the number of segregating
chromosomes is 70.
Samples from Great Apes
Six great-ape samples were genotyped in this study:
two from common chimpanzees (Pan troglodyte), one
from a bonobo (P. paniscus), two from western lowland
gorillas (Gorilla gorilla), and one from an eastern low-
land gorilla (G. g. graueri).
PCR and Sequencing Primers
Primers for DNA amplification and sequencing were
designed by MacVector, version 6.0.1. The 184-kb ge-
nomic sequence of ATM was masked for repetitive se-
quence, by Repeat Masker. Thirty-six primer sets were
designed to amplify regions containing little or no repeat
sequence, distributed evenly throughout the sequence.
Primers were selected that met strict criteria for melting
temperature and that amplified regions containing very
little or no repeat sequence. The same primers were used
for PCR and sequencing reactions and are listed in Ap-
pendix A.
PCR Amplification of Genomic DNA
Genomic DNA from five unrelated individuals was
amplified by means of 29 of the 36 primer sets men-
tioned above. The 50-ml reactions included DNA (200
ng), standard PCR buffer, dNTPs (0.1 mM each), Taq
(0.5 ml; Perkin-Elmer), and primers (1 mM each). PCR
was performed in a Perkin Elmer 9700 analyzer, with
an initial denaturation at 95C for 5 min, followed by
30 cycles of 95C for 30 s, 60C for 30 s, and 72C for
30 s, and a final step at 72C for 7 min. For all ampli-
cons, 6 ml of PCR product was run on a 1.5% agarose
gel.
DNA Sequencing
PCR products were purified and sequenced. Prepa-
ration of DNA for sequencing included incubation of
∼60 ng of PCR product with shrimp alkaline phospha-
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tase (2 U; Amersham) and exonuclease I (10 U; Amer-
sham) at 37C for 15 min, followed by enzymatic in-
activation at 80C for 15 min. Sequencing of each PCR
product was performed with the Thermo Sequenase
[33P]-radiolabeled terminator-cycle sequencing kit (Am-
ersham Pharmacia), according to the manufacturer’s in-
structions. Sequencing reactions were performed in a
Perkin Elmer 9700 analyzer, with an initial denaturation
at 95C for 1 min, followed by 35 cycles of 95C for 30
s, 55C for 30 s, and 72C for 1 min. Samples were run
on 6% polyacrylamide gels, fixed for 15 min in 5%
acetic acid/20% methanol, and dried.
Multiplex PCR
Sequencing revealed 17 SNPs in 15 different regions
of the gene. These 15 PCR amplicons were multiplexed
into two PCR reactions. Multiplex group 8 amplifies
eight fragments, and Multiplex group 7 amplifies seven
fragments. The 50-ml reactions for group 7 included
DNA (400 ng), standard PCR buffer (2#), dNTPs (0.2
mM each), and Taq (0.5 ml; Perkin-Elmer). The 50-ml
reactions for group 8 included DNA (400 ng), standard
PCR buffer (1.8#), dNTPs (0.2 mM each), and Taq
(0.5 ml; Perkin-Elmer). Primers include some of those
originally designed for sequencing and some of those
newly designed to alter the size of the amplicons. Prod-
ucts were separated by 20 bp, so that they could be
resolved from one another on a 2.5% agarose gel. Mul-
tiplex PCRs were checked to have amplified all products,
by running 6 ml of product on a 2.5% agarose gel. The
concentrations and primer sequences used for PCR are
listed in Appendix B.
Allele-Specific Oligonucleotide (ASO) Hybridizations
Genotypes for each SNPwere determined in all sample
populations, by ASO hybridizations. ASO hybridiza-
tions were performed as described by DeMarchi et al.
(1994). We performed ASO hybridization for 14 SNPs
for each individual typed. These 14 SNPs were chosen
from the original 17 because they perform consistently
well under standard ASO-hybridization conditions. Hy-
bridizations were performed under conditions that al-
lowed for annealing of only the probe that is an exact
match for the substrate DNA. Genotypes for SNPs were
read on at least two independent occasions. The se-
quences of the ASO-hybridization probes are listed in
Appendix C.
Estimation of Haplotypes and Frequencies
Haplotypes and their frequencies were estimated on
the basis of unphased genotype data, by the computer
program EMHAPFRE. Described in the work of Ex-
coffier and Slatkin (1995), EMHAPFRE uses an expec-
tation-maximization algorithm that determines themax-
imum-likelihood frequencies of multilocus haplotypes in
diploid populations. Only individuals who were scored
for all 14 SNPs were included in the data analysis.
Haplotype Assignment to Genotype Data
A short script written in Microsoft Excel Visual Basic
and named “Assign” was used to assign genotypes to
individual samples. The script was given, as input, the
list of haplotypes produced by EMHAPFRE and the raw
unphased genotype data. It produces a list of samples
input, with a pair(s) of haplotypes that satisfies the ge-
notype data assigned to each; in cases in which multiple
pairs of haplotypes were listed, one pair is chosen, by
use of a haplotype frequency–based method. A proba-
bility is calculated for each haplotype pair, by multipli-
cation of the haplotypes’ frequencies in the control pop-
ulation. The haplotype pair with the highest probability
is assigned to the individual.
Statistical Analysis for Recombination and LD
To test for recombination, we used the four-gamete
test and the Hudson and Kaplan (1985) recombination
statistic, R. For a given haplotype AB, mutation may
result in either Ab or aB. Haplotype ab arises only in
the case of either recombination or repeat mutation. The
four-gamete test was executed on unphased genotype
data, in a pairwise fashion, across all SNP loci. On the
basis of the resulting matrix of the four-gamete test, R
estimates the location and number of recombination
events that have occurred in the sample.
Initial LD analysis was computed by performance of
pairwise comparisons for all SNP loci. Fisher’s exact test
was used to determine significance levels. SNPs having
a minor-allele frequency of .05 were excluded from LD
analyses. LD statistic D is a pairwise comparison of ga-
metic frequencies such that . D′,Dp p11p22–p12p21
the relative disequilibrium, is , where′D p D/FDFmax
if andFDFmaxp max(p1p2,q1q2) D ! 0 FDFmaxp
if . D′ ranges from 1 to 1, andmin(q1p2,p1q2) D 1 0
this range is not influenced by allele frequency.
All recombination and LD statistics were generated
by the software program DnaSP 3.00 (written by J. Ro-
zas and R. Rozas, University of Barcelona).
Statistical Analysis for Association Study
Testing for significance in the model association study
was done by use of contingency tables for independence.
P values for significance of association at the haplotype
level were determined by use of 2#2 tables and 3#3
tables for the genotype level. Significance values refer to
a one-sided test.
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Figure 1 Schematic of ATM. The 184 kb of the ATM locus is illustrated, with the 64 exons represented by black boxes. Twenty-nine
∼500-bp regions were amplified by PCR in five unrelated individuals. These regions were sequenced and found to contain 17 SNPs.
Table 1
Seventeen ATM Noncoding SNPs Detected by Resequencing
SNPa
Location in Genomic Sequence with
GenBank Accession Number U82828
Prior to 5′UTR trab 10182
IVS8356trc 34293
IVS191276arg 57469
IVS2177trc 60136
IVS26491crgc 71049
IVS27193crtc 75083
IVS34754gra 85811
IVS46257arc 112721
IVS55186crt 121819
IVS573570trc 127195
IVS58997gra 132032
IVS59414grtc 133986
IVS6155trc 142611
IVS6260gra 142789
IVS62424gra 143153
IVS62973arc 151964
IVS62694cra 152243
a Nomenclature is according to the guidelines recorded by
the Ad Hoc Committee on Mutation Nomenclature (1996).
b This SNP is named in reference to the genomic sequence
having GenBank accession number U82828 because of the
highly variable nature of the 5′UTR.
c Not used in genotyping or haplotype analysis.
Results
SNP Discovery
Our initial objective was to discover common neutral
sequence variants spanning the length of the ATM gene.
A gel-based resequencing strategy was employed to de-
tect SNPs at the ATM locus. Genomic DNA of five un-
related individuals was amplified, by PCR, for [33P]-
radiolabeled sequencing. For detection of markers
spanning the entire locus, PCR primers were designed
for amplicons dispersed approximately evenly through-
out the 184-kb genomic region containing the gene (fig.
1). Approximately 13.5 kb of the 184-kb total sequence
was read in each individual. The nucleotide diversity, p,
calculated for this sequence data was .00057. Seventeen
SNPs were found, which span 142 kb and all of which
are located in introns (table 1). This yielded an average
of 1 SNP/794 nucleotides sequenced.
Genotyping and Haplotype Development
To begin construction of haplotypes from these SNPs,
we genotyped nine three-generation CEPH families
(Dausset et al. 1990). By using three-generation families,
we could determine haplotypes from genotype data,
through inference. This allowed us both to determine
the efficacy of the computer algorithm used to predict
haplotypes (see below) and to optimize our genotyping
assay. We performed ASO hybridization on nine CEPH
families (89 individuals; 70 chromosomes), for 14 of the
original 17 SNPs. These 14 SNPs were chosen from the
original 17 because they performed consistently well un-
der standard ASO-hybridization conditions.
We then used two different methods for deciphering
the haplotypes derived from the genotype data, in a side-
by-side comparison. First, haplotypes were inferred by
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Table 2
ATM Haplotypes of 295 Humans from Five Ethnic Groups and of Three Species of Great Apes
HAPLOTYPE SEQUENCE
FREQUENCY IN HUMANSa
Overall
( )np 295
African
American
( )np 71
Asian
American
( )np 39
White
European
American
( )np 77
Hispanic
American
( )np 73
CEPH
( )np 35
1 ACTCTACTTCCCTC .002 .007
2b ACTCTACTTCTTTC .313 .190 .500 .292 .315 .394
3 ACTCTCCTTCTTTC .037 .065 .048 .061
4 ACTTCACTCCTCTC .002 .007
5 ACTTTACTCTCCTCc .002
6b ACTTTACTTCCCTC .066 .218 .013 .013 .027 .015
7 ACTTTACTTCTTTC .019 .077
8 ATTCTACTTCTTTC .012 .007 .051 .007
9 ATTCTCCTTCTTTC .000 .013
10 ATTTCACTCCCCTC .002 .007
11 ATTTCATCCTCCCC .002 .013
12 TCTCTACTTCTTTC .007 .021 .015
13 TCTTCACTCTCCTC .010 .035 .007
14 TCTTCATCCTCCCC .002 .007
15b TTCTCACTCTCCTA .090 .028 .013 .175 .041 .227
16 TTTCTATCCTCCCC .005 .017 .007
17b TTTTCACCCTCCTC .100 .141 .068 .097 .110 .015
18 TTTTCACCCTCTTC .002 .007
19 TTTTCACTCCTTTC .002 .007
20 TTTTCACTCTCCTA .002 .007
21b TTTTCACTCTCCTC .048 .162 .013 .006 .027
22b TTTTCATCCTCCCC .277 .113 .291 .351 .363 .273
TTTCTACCCTCCTCc … .009
ACTTTACCCTCCTCc … .007
Total 1.000 1.000 1.000 1.000 1.000 1.000
FREQUENCY IN GREAT APES d
Chimpanzee ( )np 2 Bonobo ( )np 1 Gorilla ( )np 3
1 TCTTTACTCTCCTC .750 1.000 .000
2 TCTTTACTCTCTTC .250 .000 .000
3 TATTTACTCTCCTC .000 .000 1.000
a Samples were genotyped by ASO hybridization, then haplotypes and their frequencies were estimated from unphased genotype data, by
the EM algorithm EMHAPFRE.
b Haplotype present in all four ethnic groups studied.
c Low-frequency haplotypes in which some differences were seen in the combined data set and in individual ethnic populations.
d Samples were genotyped by ASO hybridization and fluorescent sequencing.
hand. We began with homozygotes and predicted other
haplotypes on the basis of transmission and by estab-
lishing the phase through the pedigrees. Seven haplo-
types were identified in the sample of CEPH families.
Subsequently, we subjected the same data set to an ex-
pectation-maximization algorithm, to estimate haplo-
types and their frequencies. The computer program EM-
HAPFRE is a maximum-likelihood program developed
to predict multilocus haplotypes from unphased geno-
type data (Excoffier and Slatkin 1995). It produces both
a list of haplotypes and their estimated frequencies in
the input sample population. The haplotype predictions
from EMHAPFRE were in complete accordance with
those that had been inferred manually, giving us confi-
dence that this program was suitable for data of this
nature.
Haplotype and Allele Frequencies
To determine frequencies of haplotypes and of indi-
vidual SNPs in different ethnic populations, we per-
formed ASO hybridization on anonymous African
American ( ), Asian American ( ), whitenp 71 np 39
European American ( ), and Hispanic ( )np 77 np 73
DNA samples collected in central and southeastern
Texas. Genotype data were analyzed by the EMHAPFRE
program. For the total population, 22 haplotypes and
their frequencies were predicted by EMHAPFRE (table
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Figure 2 ATM SNP allele frequencies for 14 ATM SNPs in each of four ethnic groups. A total of 260 individuals (71 African American,
39 Asian American, 77 white European American, and 73 Hispanic) were genotyped by ASO hybridization.
2). Three predominant haplotypes were found at fre-
quencies 10%. An independent study that examined
neutral sequence variants at the ATM locus also found
three major haplotypes (Li et al. 1999).
The majority of SNPs identified in this study have a
frequency, in all ethnic groups, of 25% (fig. 2). Of
the 14 SNPs, 3 (IVS191276arg, IVS46257arc,
and IVS62694cra) have a minor-allele frequency of
!10% in most ethnic groups. SNP frequencies vary
across ethnic groups. Three SNPs (IVS55186crt,
IVS62424gra, and IVS62973arc) have a frequency
of 11% in African Americans while being present at a
frequency of 130% in all other ethnic groups. SNP
IVS46257arc was not found in the samples from Af-
rican Americans. Of the three low-frequency SNPs, two
(IVS191276arg and IVS62694cra) have a fre-
quency of 118% in the white European American pop-
ulation and of !6% in the others. This is not surprising,
given that the original five samples used for SNP detec-
tion were white European Americans.
To begin to describe the haplotype phylogeny at the
ATM locus, we wanted to determine what haplotypes
were present in each ethnic population. The genotype
data were analyzed, by EMHAPFRE, as four separate
data sets segregated by ethnic group. However, this anal-
ysis led to small discrepancies from what was predicted
from the complete data set. In each case, changes were
found in the lowest-frequency haplotypes (table 2). The
efficacy of EMHAPFRE is known to decay as data sets
decrease in size (Excoffier and Slatkin 1995). Thus, a
second approach to ascription of haplotypes and their
frequencies to each ethnic group was taken. To this end,
a simple script was written in Microsoft Excel Visual
Basic. This script, named “Assign,” takes a list of hap-
lotypes and a data set of unresolved genotypes and then
assigns to each individual sample one or more pairs of
haplotypes that can resolve its genotype data; Assign lists
every pair of haplotypes that can resolve an individual’s
genotype data. We input each ethnic group’s data set
individually with the 22 haplotypes. In this way we were
able to determine which of the haplotypes suggested by
EMHAPFRE were necessary for resolution of our ge-
notype data, thus further refining the results. The ge-
notype of every sample in this study could be accounted
for by at least one pair of the 22 haplotypes predicted
by EMHAPFRE from the complete data set. Six of the
22 haplotypes exist in all ethnic populations, and 11 of
them are unique to a single population and hereafter are
referred to as “private” haplotypes (table 2); each of
these 11 haplotypes has a frequency of !1%.
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Figure 3 Four-gamete test for recombination in ATM. White boxes denote site pairs having four gametic types, which implies that
recombination has occurred between these two sites. Also shown is the Hudson and Kaplan recombination statistic R, which is an estimate of
the number and sites of recombination events needed to explain the results of the four-gamete matrix. A white box containing an “#” denotes
a potential site of recombination. The asterisk (*) denotes an SNP that is not polymorphic in the sample population.
We analyzed primate DNA in order to approximate
an ancestral ATM haplotype. Three haplotypes were
found in 12 chromosomes (table 2). Two common chim-
panzees, one bonobo, and three gorillas were genotyped
by ASO hybridization and fluorescent sequencing; in
cases in which ASO hybridization gave ambiguous re-
sults, fluorescent sequencing was used to confirm the
genotype. None of the ape haplotypes was found among
the 22 human haplotypes. One ape haplotype differs
from a human haplotype by a single-base variant. This
human haplotype is one of the least common (frequency
.007) and occurs only in our African American study
group. Only one of the human SNPs showed variation
in the apes; the remainder weremonomorphic.One com-
mon chimpanzee was heterozygous for IVS62424gra.
The gorillas shared all but one allele with the chimpan-
zees. At IVS8356trc, gorillas are homozygous for a
third allele (A), which is not found in either humans or
chimpanzees.
Intragenic Recombination and LD
The small number of haplotypes seen in our study
population suggests the possibility that recombination
is reduced at the ATM locus. This is further evidenced
by the results of the four-gamete test (fig. 3) (Hudson
and Kaplan 1985). For a given haplotype AB, muta-
tion may result in either Ab or aB. Haplotype ab arises
only in the case of either recombination or repeat mu-
tation. For the purpose of this analysis, we will consider
repeat mutation to be rare and will use the four-gamete
test as a measure of recombination. The four-gamete test
was executed on unphased genotype data, in a pairwise
fashion across SNP loci. This was done for each ethnic
group separately. Interestingly, the four-gamete test
found no site pairs with four gametes in the samples
from white European Americans, implying a complete
lack of recombination in that population. Low recom-
bination was indicated for the other groups, as shown
in figure 3.
Another test for recombination is that of Hudson and
Kaplan (1985). Based on the resulting matrix of the four-
gamete test, the Hudson and Kaplan parameter R is an
estimate of the minimum number of recombination
events in the history of the sample. For the white Eu-
ropean American population, this estimate is 0 (fig. 3).
For the other ethnic groups, R ranges from 4, in His-
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Figure 4 Fisher’s exact test for LD in ATM. White boxes denote site pairs that do not have a significant value by Fisher’s exact test,
indicating linkage equilibrium. Gray columns and rows denote SNPs that have a minor-allele frequency .05. The asterisk (*) denotes an SNP
that is not polymorphic in the sample population.
panics, to 2, in Asian Americans. The predicted sites of
recombination are similar among ethnic groups. African
Americans and Hispanics share two possible recombi-
nation sites in the 5′ end of the gene, and a third, in the
3′ end, could also be in the same location. The Asian
American population shares one of the 5′ end sites and
has, in the middle of the gene, another potential site of
recombination, which is also present in Hispanics.
Further support for the hypothesis that there is min-
imal recombination at the ATM locus is provided by the
results of Fisher’s exact test (Weir 1996). We computed
all possible pairwise comparisons between sites, to de-
termine the degree of nonrandom association between
sites. The majority of site pairs across all data sets show
significance ( ), indicating that there is extensiveP ! .001
disequilibrium at this locus (fig. 4). It has been dem-
onstrated that alleles with frequencies.05 do not have
the power for detection of disequilibrium (Lewontin
1995; Goddard et al. 2000). In this analysis, we included
only SNPs having an allele frequency 1.05. The Hispanic
and Asian American populations were in complete dis-
equilibrium. In the white European American popula-
tion, the pattern of equilibrium followed the SNP with
the lowest-frequency (.06) allele.
Disequilibrium was next measured by use of the sta-
tistic D′ , in a pairwise fashion across the 14 SNP loci
(fig. 5). , where and′D p D/FDFmax Dp p11 p1p2
if andFDFmaxp max(p1p2,q1q2) D ! 0 FDFmaxp
if . D′ ranges from 1 to 1, andmin(q1p2,p1q2) D 1 0
this range is not influenced by allele frequency. A score
of either 1 or 1 is considered to represent perfect dis-
equilibrium. Interestingly, the results of this test are vir-
tually superimposable on the results of the four-gamete
test. The majority of site pairs are in perfect disequilib-
rium. The white European American population is in
perfect disequilibrium across all sites. For the other
groups, the sites with are exactly the same sites′FD F ! 1
that have four gametes. We conclude that theATM locus
exhibits reduced recombination and extensive disequi-
librium in all four ethnic groups, with the white Euro-
pean American population being the most extreme case.
Association Study
Ultimately, we aim to use these ATM haplotypes for
association studies in populations with cancer. To eval-
uate the potential that these haplotypes have for iden-
tification of a particular mutation or polymorphism, we
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Figure 5 D′, measured as in a pairwise fashion across 14 SNP loci. A score of either 1 or 1 is considered perfect′D p D/FDFmax
disequilibrium. Black boxes denote site pairs with perfect disequilibrium; white boxes denote site pairs with . The asterisk (*) pair′FDF ! 1
denotes an SNP that is not polymorphic in the sample population.
Table 3
Frequencies for Three ATM cSNPs in the Control Population
FREQUENCY IN 941 INDIVIDUALS
White
European
Americans
African
Americans
Asian
Americans
Hispanic
Americans
cSNP1 .005 .000 .001 .001
cSNP2 .066 .001 .002 .017
cSNP3 .015 .001 .000 .005
performed a model association study. We tested the abil-
ity of these haplotypes to detect, by association, three
different cSNPs in the ATM gene. These cSNPs were
found by sequencing the reverse transcriptase–PCR
products from ATM mRNA isolated from peripheral
blood lymphocytes from cancer patients. cSNP1 is lo-
cated in exon 4 and results in Ser49Cys. Positioned in
exon 38, cSNP2 results in Asp1853Asn; and cSNP3,
which results in Pro1054Arg, is located in exon 23. A
population of 941 individuals was screened for these
three cSNPs, by ASO hybridization. The resulting fre-
quencies of the cSNPs in this population are shown in
table 3.
In the model association study, samples from white
European Americans in the 941-individual collection
that were found to possess one of the three cSNPs were
considered to be the “case” population. The “control”
population consisted of samples from white European
Americans from the same collection that were randomly
chosen and negative for the cSNPs; because of the low
frequency of these cSNPs in other ethnic groups, only
samples from white European Americans were used in
this association study. All case and control samples were
genotyped for the 14 ATM neutral sequence variants,
via ASO hybridization. To assign haplotypes to individ-
ual samples, we used Assign and the initial 22 ATM
haplotypes.
Each cSNP showed a significant association with a
different, specific ATM haplotype (table 4). cSNP1
showed an association with haplotype 2, cSNP2 with
haplotype 15, and cSNP3 with haplotype 17. Haplotype
2 was present at a frequency of .29 in the control pop-
ulation (no. of chromosomes [c] p 152) and at a fre-
quency of .64 in the cSNP1 population ( ); hap-cp 14
lotype 15 was present at a frequency of .07 in the control
population ( ) and at a frequency of .57 in thecp 112
cSNP2 population ( ); and haplotype 17 was pre-cp 56
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Table 4
Association of ATM Haplotypes and ATM cSNPs in Individual “Case” and Control Populations
HAPLOTYPE
FREQUENCY IN a P FOR
Control
Population
“Case”
Population
Genotype
Associationb
Haplotype
Associationc
cSNP1 2 .29 ( )cp 152 .64 ( )cp 14 .0478 .0166
cSNP2 15 .07 ( )cp 112 .57 ( )cp 56 .0000 .0000
cSNP3 17 .08 ( )cp 146 .52 ( )cp 54 .0000 .0000
NOTE.—Samples carrying one of three ATM cSNPs were genotyped, by ASO hybridization, for
the 14 ATM noncoding SNPs.
a Each cSNP was found to occur on separate ATM haplotypes. c p total number of white
European American chromosomes genotyped.
b By 2#2 contingency table.
c By 3#3 contingency table.
Table 5
Association of ATM Haplotypes and ATM cSNPs in Combined
Case Population
HAPLOTYPE
FREQUENCY IN
COMBINED
CASE POPULATION
( )cp 124
P FOR
Genotype
Association
Haplotype
Association
2 .19 .9644 .7606
15 .27 .0000 .0002
17 .24 .0000 .0002
NOTE.—See footnotes to table 4.
sent at a frequency of .08 in the control population
( ) and at a frequency of .52 in the cSNP3 pop-cp 146
ulation ( ). These are 2-fold, 8-fold, and 6.5-foldcp 54
increases in the frequencies of haplotypes 2, 15, and 17,
respectively; and the P values for these associations are
.0166, .0000, and .0000, respectively. Genotype corre-
lations were also present, with P values of .0478, .0000,
and .0000, respectively (table 4).
One of the great challenges in studying the genetics
of a complex disease such as cancer is its multifactorial
etiology. As presented in table 4, the data from our sim-
ulated association study model a scenario in which all
“cases” are caused by a single mutation. To more ac-
curately simulate an association study with a complex
disease, we reanalyzed our data. We considered the three
groups of samples carrying the variant cSNPs as one
“case” population. In this analysis, two of the three hap-
lotypes that originally had shown an association dem-
onstrated a significant increase in frequency (table 5).
No increase in frequency was apparent for haplotype 2,
which had previously shown a twofold increase in the
cSNP1 population; haplotype 15 showed a fourfold in-
crease ( ); and haplotype 17 showed a three-Pp .0002
fold increase ( ). Thus, we successfully dem-Pp .0002
onstrated the ability of these ATM haplotypes to discern
members of our case population who carry a particular
SNP. The results of these studies indicate a significant
potential for the use of haplotypes extending over a large
genomic region, to detect disease associations through
a case-control–study design in a general population.
Discussion
In this study, we have presented a strategy for uncovering
the genetic contribution to complex disease. Specifically,
we have demonstrated the utility of a complex SNP-
based–haplotype approach to association studies and
have detected significant LD at theATM locus, extending
∼142 kb. The results of this study provide proof of prin-
ciple for the use of SNP-haplotype data in the detection
of genetic factors contributing to complex disease.
We sequenced 13.5 kb of the ATM gene in five un-
related individuals and detected 17 SNPs in noncoding
regions. We then utilized these neutral sequence variants
spanning 142 kb of the ATM gene to construct hap-
lotypes for this genomic locus. The expectation-maxi-
mization algorithm EMHAPFRE (Excoffier and Slatkin
1995) was used to predict haplotypes from genotype
data on 295 individuals from four ethnic groups.
Twenty-two haplotypes and their frequencies were pre-
dicted by EMHAPFRE, for the total population. Three
of these 22 haplotypes have a frequency of10%. This
concurs with the findings of Li et al. (1999), who also
used neutral sequence variants to detect three major
haplotypes at the ATM locus. Six of the 22 haplotypes
exist in all four ethnic populations in our study and are
also the most commonly occurring haplotypes. There
are 11 private haplotypes, each of which has a frequency
of !1%.
We verified the reliability of the haplotype-prediction
algorithm by using several tests. First, we genotyped
individuals from nine three-generation CEPH families
( ). This allowed us to determine haplotypes bynp 87
inspection of allele segregation. The CEPH genotype
data were also analyzed by EMHAPFRE, and the re-
sulting haplotypes agreed completely with those in-
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ferred on the basis of transmission data. Next, we used
Assign, a script written in Microsoft Excel Visual Basic,
to assign pairs of haplotypes to individual genotypes.
Given the 22 haplotypes predicted by EMHAPFRE, As-
sign successfully resolved the genotype data for all 295
individuals in this study. The results of EMHAPFRE
were tested against another haplotype-prediction pro-
gram, one that does not use the expectation-maximi-
zation algorithm and that does not assume that Hardy-
Weinberg is in effect. This program, termed “Data
Mining,” uses the resulting matrix of the four-gamete
test to inform the process of haplotype prediction so
that recombination may influence outcome (N. Wang,
R. Chakraborty, M. Kimmel, and L. Jin, personal com-
munication). There were minor differences in the results
of this comparison. For the population of white Eu-
ropean Americans, the outcome of each program was
identical. This is not surprising, since the four-gamete
test reveals no evidence for recombination in this pop-
ulation. The results of these trials confirm that EM-
HAPFRE was successful in estimating the correct hap-
lotypes necessary to sufficiently resolve our data set. We
feel confident that the size and diversity of our data set
has allowed us to describe in relative depth the hap-
lotype architecture ofATM.Consequently, we have cho-
sen to use, as the foundation for further studies, the 22
haplotypes predicted from the complete data set.
With a minimal amount of sequencing (13.5 kb in
five individuals), we were able to detect highly infor-
mative neutral sequence variants spanning a large ge-
nomic region. In sequencing 10 chromosomes form
white European Americans, we found SNPs that have
a common occurrence in four different ethnic groups.
In all ethnic groups, the majority (11 of 14) of SNPs
identified in this study have a minor-allele frequency of
25%. SNPs with frequencies in the range of .2–.5 have
the highest information content for association and LD
studies (Kruglyak 1997). Although most SNPs had a
high minor-allele frequency in all ethnic groups, allele
frequencies varied across ethnic groups. This is in ac-
cordance with several other studies that have found
population differences in SNP-allele frequencies (Lai et
al. 1998; Nickerson et al. 1998; Cargill et al. 1999;
Halushka et al. 1999; Goddard et al. 2000). Variations
in allele frequencies are most pronounced in the Afri-
can American population. Four SNPs (IVS2177trc,
IVS55186crt, IVS62424gra, and IVS62973arc)
have a minor-allele frequency that is reduced by
40%–75% in African Americans, compared with that
in other ethnic groups. A fifth SNP, IVS46257arc,
was not found in the African American samples. These
differences illustrate that there is population structure
in SNP-allele frequencies that is an important factor to
consider when SNP-based association and LD studies
are designed.
Comparison of genotype data from six great apes was
instructive for approximating ancestral haplotypes and
SNP alleles. Genotyping revealed three haplotypes in
this population, none of which is identical to the human
ATM haplotypes. Of the 14 SNPs, 2 showed variation
in the ape population. One common chimpanzee was
heterozygous for IVS62424gra, and all three goril-
las were homozygous for a third allele (A) at IVS8
356trc. The extent of homozygosity in this sample in-
dicates that most of the SNPs found varying in the hu-
man population have arisen since the divergence of the
human lineage from the last common ancestor shared
with the chimpanzee. This agrees with the assertion by
Hacia et al. (1999)—that is, that most current neutral
human polymorphisms are not shared with the chim-
panzee (Hacia et al. 1999). It may also imply that these
SNPs are not hypermutable sites, since more variation
might be expected in the 12 primate chromosomes an-
alyzed. Although these SNPs are common in man, they
are not due to hypermutability; rather, they are old
enough to be found throughout diverse ethnic groups.
The results of this study show a remarkable lack of
recombination at the ATM locus. This effect is most
profound in the white European American population,
in which no evidence for recombination is detected by
the four-gamete test and in which D′ shows perfect dis-
equilibrium across all SNPs. Low recombination is im-
plicated for the African American, Asian American, and
Hispanic groups as well. The possibility of low recom-
bination was suspected on the basis of the seemingly
small number of haplotypes found at this locus. Twenty-
two haplotypes with 14 loci is not considerably greater
than the (i.e., 15) that would be expected if theren 1
is no recombination. Another study, performed in par-
allel with this one, used the same approach as that de-
scribed here and serves as a direct comparison: D.
Trikka, Z. Fang, A. Renwick, S. Jones, R. Chakraborty,
M. Kimmel, and D. L. Nelson (unpublished data) used
neutral sequence variants dispersed across the BLM,
WRN, and RECQL loci, to derive haplotypes for these
regions; their study used the same sample population,
with fewer SNPs (8, 13, and 11 respectively) for hap-
lotype construction, and found considerably larger
numbers of haplotypes (50, 56, and 47, respectively) at
each locus. The key difference between these loci and
ATM is the amount of recombination and LD reported.
Trikka et al. found more evidence for recombination
and linkage equilibrium when the four-gamete test and
Fisher’s exact test were used. For ATM, the four-gamete
test revealed few site pairs with four gametes. The Hud-
son-Kaplan recombination statistic R ranged from 0, in
white European Americans, to 4, in Hispanics. Analysis
by both Fisher’s exact test and D′ indicated extensive
LD for ATM, in all ethnic groups studied. Figure 5
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shows extensive disequilibrium, with 172% of site pairs
having perfect disequilibrium in all ethnic groups.
Using a model association study, we have successful-
ly demonstrated the ability of ATM haplotypes to iden-
tify chromosomes carrying specific coding polymor-
phisms. The three cSNPs that we used as candidates for
detection had varying frequencies in our control pop-
ulation of white European Americans (cSNP1, .005;
cSNP2, .066; and cSNP3, .015). When each of the three
cSNP populations was analyzed individually, each cSNP
showed a significant association with a different ATM
haplotype. cSNP1 showed an association with haplo-
type 2, cSNP2 with haplotype 15, and cSNP3 with hap-
lotype 17 ( , .0000, and .0000, respectively);Pp .0166
the increase in haplotype frequency in cases versus con-
trols was 2-fold, 8-fold, and 6.5-fold, respectively. To
model the potential for multiallelic etiology of a com-
plex disease, we combined the three populations of sam-
ples carrying the cSNPs into one “case” population. In
this analysis, two haplotypes demonstrated a readily
detectable increase in frequency: haplotype 15 showed
a fourfold increase, and haplotype 17 showed a three-
fold increase in frequency; no frequency increase was
apparent for haplotype 2, which had previously shown
a twofold increase in the cSNP1 population.
The association that becomes undetectable (i.e., hap-
lotype 2 with cSNP1) involves the haplotype occurring
most commonly (frequency .29) in the general popu-
lation. Haplotype 15 shows the greatest increase in fre-
quency and is the least common of the three haplotypes,
with a control frequency of .05. This leads us to an
important point for future association studies. Haplo-
types with lower frequencies in control populationsmay
bemore effective for detection of associations.However,
it is important to note that haplotype 17, which is the
third most frequent haplotype (frequency .10), never-
theless showed a 2.6-fold increase in frequency in the
combined cSNP population. An additional factor con-
tributing to detection in this study is frequency of the
mutation. In the case of cSNP1 and haplotype 2, in
which the association becomes undetectable, the most
frequent haplotype was associated with the least com-
mon SNP (cSNP1, .006). The difference in frequency
between cSNP1 and the other cSNPs is a factor of 10.
Both the haplotype frequency and the cSNP frequency
contribute to detection. This underscores the idea that
several factors, including frequency of haplotype, fre-
quency of mutation, and age of mutation, contribute to
limits of detectability.
This model association study demonstrates proof of
principle for the use of complex SNP haplotypes cov-
ering candidate genes, in the detection of genetic factors
contributing to complex disease. We have successfully
demonstrated the ability of these ATM haplotypes to
discern members of our “case” population that carry a
particular coding SNP. The results of these studies in-
dicate that haplotypes extending over a large genomic
region have a significant potential for detection of dis-
ease associations.
There is much interest in the use of SNPs in ge-
nomewide association studies and other LD-based strat-
egies. Our approach and analyses bear on those strat-
egies, in several regards. First, LD estimates from
simulation studies have been as low as 3 kb of mean-
ingful LD (Kruglyak 1999). This calculation suggests
that a very-high-density map with as many as 0.5–3
million SNPs would be necessary for effective associa-
tion studies (Kruglyak 1999). Our results and those of
other studies (Collins et al. 1999; Eaves et al. 2000;
Moffatt et al. 2000; Taillon-Miller et al. 2000) indicate,
to the contrary, that significant LD can be found ex-
tending as far as several hundred kilobases. This should
reduce the number of SNPs necessary for genomewide
linkage studies. Comparison of LD at ATM versus the
results of the LPL study (Clark et al. 1998) in which
LD patterns were complex over just 9.7 kb supports the
idea that LD varies widely throughout the genome, in-
dicating that some regions will require SNPs that are
more densely spaced. Second, higher-frequency (.2–.5)
SNPs are more robust, whereas rare SNPs may be less
useful and, in some analyses, may confound results.
More than half of the SNPs used to construct haplotypes
in the LPL study had a relative allele frequency of !.2.
This resulted in 67 of 71 individuals having a unique
haplotype. By using fewer markers (14) with higher fre-
quency (.20), we were able to effectively elucidate the
haplotype architecture and the LD and recombination
profiles for the ATM genomic locus (142 kb). These
haplotypes were used successfully in association studies,
to detect coding polymorphisms in the ATM gene. We
conclude that reasonably spaced, highly informative
SNPs have the ability to define a larger number of an-
cestral chromosomes and have increased power for pop-
ulation-based association studies.
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Appendix A
Primers Used for PCR and Sequencing
f1.atm, ATGGTCATCTCGTTACAGGCAATGC
r1.atm, CCCCAAGTGACTGAAGGCATCTAGG
f2.atm, TGGTGGAACCATTTCCGTTTAACG
r2.atm, GCGCCCTTCTAATAACCCGCC
f3.atm, GCCCAGAACCTCCGAATGACG
r3.atm, CGACTTAGCGTTTGCGGCTCG
f4.atm, TGGCTGGCAACATTACCAACTGC
r4.atm, TGCATCTTTTTCTGCCTGGAGGC
f5.atm, TGTGTGCTAGGGAGGAATCTGGTGG
r5.atm, GGCTGTCTCTAGGCTTGTTGAGGGC
f6.atm, CCATCATCCGAAAGGAGCCAAAAC
r6.atm, GCAGCAATTTCCCTGTTTCTGCC
f7.atm, AAATTGGCAGGATGATGAGGATGC
r7.atm, GCTGTCAAGCTGCATCAGCGTTAG
f8.atm, CCAAAGCGTGCCAGAATGGTATG
r8.atm, CCAAAGCGTGCCAGAATGGTATG
f9.atm, GGTATGCGTAGCGGGGCTAGTGAG
r9.atm, CGCAGGAAAAAGCCAGATGCAATC
f10.atm, GCCCTAGCCCCAGTGTATGTGGAG
r10.atm, GGCAGCCAGTTTCCGAGAACTACC
f11.atm, TTTTTGGCAAGGTGAGTATGTTGGC
r11.atm, TGCGAACTTGGTGATGATTGTCAGC
f12.atm, AGATTGTTCCAGGACACGAAGGGAG
r12.atm, TTTCTTCCCATTGTCACCTGTTCCC
f13.atm, TGCGAAAAACAGGCTTTGTTTGC
r13.atm, GGTGATGGAAAAGAGACGGGGC
f14.atm, GCAAGTCCCCTCACCAGCAACAC
r14.atm, GATGCCTTCCCATCATCCTGATACC
f15.atm, TCTGGGAAGAAGTTACGCAGGGAAC
r15.atm, CTGACTGGCACTAGAATTTGCTGGC
f16.atm, GGCGGAATGAATGTGAGTTATGCG
r16.atm, CCAGGTGATTTCTCCATCCCGTG
f17.atm, CTGCCTAAAGCAGCAGTTTTTGCC
r17.atm, TGTTGCTATCCCGAAGCTGAAACC
f18.atm, GGTGTGTAAGCAAGAATGCCTGGG
r18.atm, GCCACAGATTTTGAGACCACTGCAC
f19.atm, TAGTTTGTATGGCTGTGGTGGAGGG
r19.atm, CATCCCTCTGCTTCAGGAGTATCCC
f20.atm, CCAGTAGGGGGTCCCTCATTTCC
r20.atm, TGAGAAGCTGGGAGTGTTTCTGCC
f21.atm, CCCCGTACATGAAGGGCAGTTG
r21.atm, TGGGTGGCTGGGCTAATGAAGAG
f22.atm, GGTTCAGCGAGAGCTGGAGTTGG
r22.atm, GCAGCAGGGGGAAAACCCAC
f23.atm, CCACAGATTAGCAACAAGTTGGGGC
r23.atm, TGGCATAAGCACACGGAAACTCTCC
f24.atm, AGGTTCCGATGGCAAGGAGAGG
r24.atm, CTGTGTCTTTCCACCACTCCCCAG
f25.atm, CAGTCATGGTTCTGGGGAGAGAAGC
r25.atm, GCCTTTCTGATTTCCCTTCCTGCC
f26.atm, CTTGATGGTGGGAGGGACTTAGGG
r26.atm, TGCCTAGATGTTTGAGAGCCTGCC
f27.atm, CAGGGCACACAGGGTACAGTGTAGG
r27.atm, TCAGTTCAGACCATCTCATGCCTCC
f28.atm, CAGGGGGATGATAGTGATGATGTGG
r28.atm, TTCAAAACATACATGCCCTGCCTTC
f29.atm, CAAAGACTGAGAGCTGAGCCCAGTG
r29.atm, GCACAATCTCCTCCTTTCTGCTGC
f30.atm, TGGTTTAGAAATGCCTTCAGCCCC
r30.atm, TGCACTCTACCTGCCATGCTTCC
f31.atm, GCCATGTCAGTGCCCAACTTGAAG
r31.atm, TTGGTGCTGCGTTTGGAATCTTG
f32.atm, GATTCCAAACGCAGCACCAAACC
r32.atm, GGTAGTTGATGGGGGAGGGGAAC
f33.atm, GTTCCCCTCCCCCATCAACTACC
r33.atm, GAGCACAGTGCCTTCTTCCACTCC
f34.atm, CCCTGACAATCTGGGGCACAAAC
r34.atm, CCGTGGCTTTTGCTGGCATTC
f35.atm, GTCCTGTGGCATTGTGCATAACTCC
r35.atm, GCAGACATTAGGCATAAGCCCCTTC
f36.atm, GATGACTGCCCTTGTTCCCCAAG
r36.atm, TGGTTAAGTTGCTTTTCCCCCCAG
Appendix B
Primer Sequences and Concentrations Used for Multiplex PCR
Group 8:
3F ATM, 5′-GCCCAGAACCTCCGAATGACG-3′; and 3R-2 ATM, 5′-GCCGTGAAGCGAAAGAGGCG-3′ (0.25 mM)
11F ATM,5′-TTTTTGGCAAGGTGAGTATGTTGGC-3′; and 11R ATM, 5′-TGCGAACTTGGTGATGATTGTCAGC-3′ (0.25 mM)
14F ATM, 5′-GCAAGTCCCCTCACCAGCAACAC-3′; and 14R ATM, 5′-GATGCCTTCCCATCATCCTGATACC-3′ (0.25 mM)
23F-2 ATM, 5′-GGTGGAATCTGGTCTAGTTACCC-3′; and 23R ATM, 5′-TGGCATAAGCACACGGAAACTCTCC-3′ (0.25 mM)
27F ATM, 5′-CAGGGCACACAGGGTACAGTGTAGG-3′; and 27R ATM, 5′-TCAGTTCAGACCATCTCATGCCTCC-3′ (0.188 mM)
29R ATM, 5′-CAAAGACTGAGAGCTGAGCCCAGTG-3′; and 29R ATM, 5′-GCACAATCTCCTCCTTTCTGCTGC-3′ (0.125 mM)
30F ATM, 5′-TGGTTTAGAAATGCCTTCAGCCCC-3′; and 30R-2 ATM, 5′-CAGCCAGTCCAACATAAATCAG-3′ (0.25 mM)
31F ATM, 5′-GCCATGTCAGTGCCCAACTTGAAG-3′; and 31R ATM, 5′-TTGGTGCTGCGTTTGGAATCTTG-3′ (0.25 mM)
Group 7:
7R ATM, 5′-GCTGTCAAGCTGCATCAGCGTTAG-3′; and 7F-2 ATM, 5′-GTTGGATTACCATGTTCACCAG-3′ (.188 mM)
10F ATM, 5′-GCCCTAGCCCCAGTGTATGTGGAG-3′and 10R-2 ATM, 5′-GCAGAGATAATCATGGGCAGG-3′ (0.25 mM)
15F ATM, 5′-TCTGGGAAGAAGTTACGCAGGGAAC-3′; and 15R-2 ATM, 5′-TGGGGAGACTATGGTAAAAGAGG-3′ (0.31 mM)
16F ATM, 5′-GGCGGAATGAATGTGAGTTATGCG-3′; and 16R ATM, 5′-CCAGGTGATTTCTCCATCCCGTG-3′ (0.25 mM)
20F ATM, 5′-CCAGTAGGGGGTCCCTCATTTCC-3′; and 20R ATM, 5′-TGAGAAGCTGGGAGTGTTTCTGCC-3′ (0.25 mM)
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25F ATM, 5′-CAGTCATGGTTCTGGGGAGAGAAGC-3′; and 25R-2 ATM, 5′-CTATCAATATCTAGCTCTGGGGC-3′ (0.15 mM)
28F ATM, 5′-CAGGGGGATGATAGTGATGATGTGG-3′; and 28R ATM, 5′-TTCAAAACATACATGCCCTGCCTTC-3′ (0.5 mM)
Appendix C
Probes Used for ASO Hybridization
ATMAso 3T, 5′-TAACCCTCCTTCCCGC-3′
ATMAso 3a, 5′-TAACCCTCCATCCCGC-3′
ATMAso 7T, 5′-AAGGAACTTGTAATATTTTTC-3′
ATMAso 7c, 5′-AGGAACTCGTAATATTTTTC-3′
ATMAso 10T, 5′-TGGGAAACATGACCAGGG-3′
ATMAso 10c, 5′-GGGAAACACGACCAGGG-3′
ATMAso 11T, 5′-GTAACTTATAATAACCTTTC-3′
ATMAso 11c, 5′-GAAGTAACTTACAATAACC-3′
ATMAso 14C, 5′-TCTGTACAAGAAAAATTTG -3′
ATMAso 14g, 5′-TCTGTAGAAGAAAAATTTG-3′
ATMAso 15C, 5′-TTTCCTCTCAGTCTACAGG-3′
ATMAso 15t, 5′-TTTTTCCTCTTAGTCTACAGG-3′
ATMAso 16C, 5′-TAGAGATGATGTCGGCTTC-3′
ATMAso 16t, 5′-CTAGAGATGATGTTGGCTTC-3′
ATMAso 20A, 5′-GTAATGTCAGAGTATTAAA-3′
ATMAso 20c, 5′-TAATGTCAGCGTATTAAA-3′
ATMAso 23T, 5′-CAAAAGCTTCTCTTGCTTT-3′
ATMAso 23c, 5′-AAAAGCTTCTCCTGCTTTC-3′
ATMAso 25C, 5′-TTTTTTGTGGCATTCACAC-3′
ATMAso 25t, 5′-TTTTTTGTGGTATTCACAC-3′
ATMAso 27C, 5′-CTGCTCATGCCTCCTCTC-3′
ATMAso 27t, 5′-CTGCTCATGTCTCCTCTCC-3′
ATMAso 28C, 5′-TTCTATTAAACAGTATTA-3′
ATMAso 28a, 5′-TTCTATTAAAAAGTATTA-3′
ATMAso 29.1T, 5′-GATAAAGATATGTTGACAA-3′
ATMAso 29.1c, 5′-GATAAAGATACGTTGACAA-3′
ATMAso 29.2C, 5′-ACTTCCTGACGAGATACAC-3′
ATMAso 29.2t, 5′-ACTTCCTGATGAGATACAC-3′
ATMAso 30c, 5′-CCTAAGCCACGTTCCTCTA-3′
ATMAso 30t, 5′-CCTAAGCCATGTTCCTCTA-3′
ATMAso 31.1C, 5′-AAATAGAGCGATTTTGGTT-3′
ATMAso 31.1t, 5′-AAATAGAGAGATTTTGGTTC-3′
ATMAso 31.2C, 5′-AGAAATTCCTCATGAACTC-3′
ATMAso 31.2a, 5′-AGAAATTCATCATGAACTC-3′
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